StreetInsider.com News Articles

Form 8-K Envoy Medical, Inc. For: Oct 12

Fri, 16 Oct 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20261016/27198260.html

H.C. Wainwright Reiterates Buy Rating on Envoy Medical (COCH)

Tue, 13 Oct 2026 06:52:36 -0400

H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $2.00 price target on Envoy Medical (NASDAQ: COCH).

The analyst commented: 'Yesterday, Envoy Medical announced the submission of the second module of its modular premarket approval (PMA) application to the FDA for the fully implanted Acclaim cochlear implant. As a reminder, the first module was submitted on June 30, 2026. Management noted that the company is on track to complete the application with the fourth and final clinical module to be submitted towards the end of 2Q27. Importantly, the rolling submission approach allows the FDA to review submitted sections while clinical

Envoy Medical files second FDA module for Acclaim cochlear implant

Mon, 12 Oct 2026 08:31:57 -0400

Envoy Medical Inc. (NASDAQ: COCH) submitted the second module of its Modular Premarket Approval application to the U.S. Food and Drug Administration for its Acclaim cochlear implant, the company announced Oct. 12, 2026.

The second module, which contained primarily engineering information, follows the first module submitted on June 30, 2026. Envoy Medical plans to submit a total of four modules on a rolling basis, with the final module expected to include clinical trial data. The company targets completion of the final module submission by the end of the second quarter of 2027.

The rolling submission structure allows the FDA to review completed

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

Mon, 12 Oct 2026 08:30:00 -0400

Second of Four Planned Modules Moves Rolling FDA Review Forward

Advances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027

White Bear Lake, Minnesota--(Newsfile Corp. - October 12, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced the submission of the second module of its Modular Premarket Approval ("PMA") application to the U.S. Food and Drug Administration ("FDA") for the Acclaim® cochlear implant, which has received FDA Breakthrough Device Designation.

The second module, which included primarily engineering information, follows

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

Mon, 12 Oct 2026 08:30:00 -0400

Second of Four Planned Modules Moves Rolling FDA Review Forward

Advances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027

The second module, which included primarily engineering information, follows

Form 8-K Envoy Medical, Inc. For: Oct 06

Wed, 07 Oct 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20261007/27158882.html

Lake Street Starts Envoy Medical (COCH) at Buy

Tue, 06 Oct 2026 09:56:25 -0400

(Updated - October 6, 2026 9:56 AM EDT)

Lake Street analyst Frank Takkinen initiates coverage on Envoy Medical (NASDAQ: COCH) with a Buy rating and a price target of $2.50.

The analyst comments "Envoy Medical (COCH - Buy, $2.50 PT) - Envoy is developing Acclaim, a fully implantable cochlear implant targeting a $1B existing market and potential $84B TAM. Stage 1 pivotal data came in line with external devices at 12 months, de-risking the trial ahead of 2H27/1H28 approval. Envoy is funded to key catalysts, and we think strategic interest will be significant. We think 1H27 data and FDA submission are catalysts

Lake Street Starts Envoy Medical (COCH) at Buy

Tue, 06 Oct 2026 09:56:25 -0400

(Updated - October 6, 2026 9:56 AM EDT)

Lake Street analyst Frank Takkinen initiates coverage on Envoy Medical (NASDAQ: COCH) with a Buy rating and a price target of $2.50.

Envoy Medical receives two new patents, expanding portfolio to 97

Tue, 22 Sep 2026 08:32:49 -0400

Envoy Medical Inc. (NASDAQ: COCH) announced the grant of two international patents, bringing its total global patent portfolio to 97, comprising 40 U.S. and 57 foreign patents. The company also holds 35 pending applications, including 26 foreign and 9 U.S., according to a press release.

The Canadian Patent Office granted Canadian Patent No. 3,130,978, titled "Implantable Cochlear System with Integrated Components and Lead Characterization." The patent covers technology related to characterizing electrical conductors within an implantable cochlear system.

The Hong Kong Patent Office granted Hong Kong Patent No. HK40108431, titled "Implantable Cochlear System and Corresponding Method of Compensating for Variability in a

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

Tue, 22 Sep 2026 08:30:00 -0400

Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy Medical's Fully Implanted Hearing Platform

White Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the grant of two additional international patents, expanding its global intellectual property portfolio to 97 patents, consisting of 40 U.S. and 57 foreign patents. In addition, the Company has 26 pending foreign applications and 9 pending U.S. applications.

"As a company known for fully implanted hearing devices that leverage the natural ear

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

Tue, 22 Sep 2026 08:30:00 -0400

Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy Medical's Fully Implanted Hearing Platform

"As a company known for fully implanted hearing devices that leverage the natural ear

Form SCHEDULE 13G/A Envoy Medical, Inc. Filed by: Alta Partners LLC

Mon, 14 Sep 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260914/27058734.html

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

Wed, 02 Sep 2026 08:30:00 -0400

White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) - Envoy Medical^® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that Brent Lucas, Envoy Medical's Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, on September 14-16, 2026 at the Lotte New York Palace Hotel in New York City.

H.C. Wainwright Conference Presentation Details:
Presentation Date: Tuesday, September 15, 2026
Presentation Time: 2:00 PM ET
Location: Kennedy II Room, Lotte New York Palace Hotel, New York, NY
Webcast Link: https://ir.envoymedical.com/news-events/ir-calendar

To schedule a one-on-one

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

Wed, 02 Sep 2026 08:30:00 -0400

To schedule a one-on-one

Form 8-K Envoy Medical, Inc. For: Aug 24

Thu, 27 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260827/26991399.html

Form 8-K Envoy Medical, Inc. For: Aug 24

Thu, 27 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260827/26991399.html

Form 4 Envoy Medical, Inc. For: Aug 24 Filed by: Potashnick Robert

Wed, 26 Aug 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260826/26982752.html

Form 4 Envoy Medical, Inc. For: Aug 24 Filed by: Potashnick Robert

Wed, 26 Aug 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260826/26982752.html

Envoy Medical (COCH) PT Lowered to $2 at H.C. Wainwright

Fri, 21 Aug 2026 07:02:57 -0400

(Updated - August 21, 2026 7:02 AM EDT)

H.C. Wainwright analyst Yi Chen lowered the price target on Envoy Medical (NASDAQ: COCH) to $2.00 (from $2.50) while maintaining a Buy rating.

The analyst commented: "Envoy Medical recently reported its 2Q26 financial results. Revenue was $51K. Net loss was $7.3M, or ($0.07) per share, slightly higher than our estimated loss of $6.6M. Importantly, the company submitted the first of four planned modules of a modular premarket approval (PMA) application to the FDA for the Acclaim cochlear implant in June 2026, with the final clinical module targeted for submission in 2Q27. In July, the

Envoy Medical (COCH) PT Lowered to $2 at H.C. Wainwright

Fri, 21 Aug 2026 07:02:57 -0400

(Updated - August 21, 2026 7:02 AM EDT)

H.C. Wainwright analyst Yi Chen lowered the price target on Envoy Medical (NASDAQ: COCH) to $2.00 (from $2.50) while maintaining a Buy rating.

Form PRE 14A Envoy Medical, Inc. For: Aug 19

Wed, 19 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260819/26950504.html

Form PRE 14A Envoy Medical, Inc. For: Aug 19

Wed, 19 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260819/26950504.html

New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA

Sat, 15 Aug 2026 10:40:00 -0400

Envoy Medical, Sagtec Global, RHINO Bitcoin and Virtuix Holdings Featured in This Weekend's Global Broadcast

New to The Street Expands Its International Footprint with "Nuevo a la Calle™" Across Latin America and Programming Across the Middle East & North Africa

NEW YORK, NY / ACCESS Newswire / August 15, 2026 / NEW YORK, August 15, 2026 - New to The Street®, the 18-year financial and business media platform, announces its latest sponsored-programming broadcast airing this weekend across Bloomberg Television in the United States, Latin America and the Middle East & North Africa (MENA).

New

New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA

Sat, 15 Aug 2026 10:40:00 -0400

Envoy Medical, Sagtec Global, RHINO Bitcoin and Virtuix Holdings Featured in This Weekend's Global Broadcast

New to The Street Expands Its International Footprint with "Nuevo a la Calle™" Across Latin America and Programming Across the Middle East & North Africa

New

New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA

Sat, 15 Aug 2026 10:40:00 -0400

Envoy Medical, Sagtec Global, RHINO Bitcoin and Virtuix Holdings Featured in This Weekend's Global Broadcast

New to The Street Expands Its International Footprint with "Nuevo a la Calle™" Across Latin America and Programming Across the Middle East & North Africa

New